Rayno 2016 Life Science Portfolio Update By: TalkMarkets September 29, 2016 at 21:14 PM EDT Biotech stocks are near their intermediate highs but still down in 2016 : IBB at $295 down 12.78% and the XBI at $67.80 down 3.42% YTD. Read More >> Related Stocks: AbbVie Amgen Bluebird Bio Bristol-Myers Squibb Foundation Medicine Gilead Sciences Illumina Inc Nasdaq Biotechnology Ishares ETF Roche Holding AG Basel American Depositary Shares S&P Biotech SPDR Thermo Fisher Scientific